CRISIL Downgrades Tatva Chintan Pharma Ratings on Bank Facilities

Imagine a company called Tatva Chintan Pharma.

A company that checks how safe and sound other companies are, called CRISIL, has lowered their rating of Tatva Chintan's ability to pay back loans.

This means CRISIL thinks Tatva Chintan might be facing some problems.

The company's sales went down a little, and they made less profit because of things like lower prices and problems with one of their main products.

The company still has strengths, like experience, but there are also concerns about its financial health, especially with its market presence in China.